After receiving both CE mark and FDA approval for its new coronary imaging catheter, Boston Scientific has announced that it has launched the “OptiCross” in Europe and in the USA. It plans to launch the catheter in Japan later this month.
According to a press release, the OptiCross is a next-generation intravascular ultrasound (IVUS) catheter that offers better deliverability and higher resolution imaging to facilitate complex coronary procedures.
The press release reported that the device is designed to be compatible with the Boston Scientific iLab ultrasound imaging system and was created with the input of physicians from around the world to reduce the inherent challenges surrounding catheter delivery in complex cases. The upgraded, low-profile delivery system features five French guide catheter compatibility, a shorter, tapered tip, a bi-segmented catheter shaft and a redesigned catheter hub for ease of connection.
“The OptiCross catheter was designed for optimal deliverability and its performance proves it,” said Matthew Price, interventional cardiologist and director of the Cardiac Catheterization Laboratory, Scripps Green Hospital, San Diego, USA. “Now I can use IVUS technology in complex cases where I would not have been able to deliver an IVUS catheter before.”
